Allspring Global Investments Holdings, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50,743
-99.8%
4,424
-99.6%
0.00%
-100.0%
Q2 2023$28,634,746
-42.2%
1,131,361
-26.4%
0.05%
-43.9%
Q1 2023$49,514,822
+145.1%
1,537,250
+40.4%
0.08%
+141.2%
Q4 2022$20,204,912
+27.7%
1,094,524
+86.7%
0.03%
+21.4%
Q3 2022$15,828,000
+316460.0%
586,275
+151392.2%
0.03%
Q2 2022$5,000
-87.2%
387
-80.7%
0.00%
Q1 2022$39,000
+30.0%
2,005
+6.9%
0.00%
Q4 2021$30,0001,8750.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders